v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss including noncontrolling interest $ (3,524,461) $ (1,449,870)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization of property and equipment 24,231 20,362
Amortization of debt issuance costs 106,953 34,310
Amortization of discount on debt 548,827 311,263
Stock based compensation 808,651 387,976
Issuance of common stock in lieu of debenture interest    36,986
Loss on extinguishment of debentures and notes 90,205 16,923
Provision for accounts receivable doubtful accounts 26,740   
Provision (Recoveries) from other receivables doubtful accounts (105,087) 2,027
(Gain) or loss on change in fair value of warrant liability 275,350 (106,231)
Changes in operating assets and liabilities:    
Accounts receivable (63,883) (49,969)
Inventories 185,781 44,228
Other Receivables 177,768   
Prepaid expenses and other current assets (68,406) 116,131
Accounts payable and accrued liabilities 1,108,260 (4,866)
Net cash used in operating activities (409,071) (640,730)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (21,285) (8,213)
Net cash used in investing activities (21,285) (8,213)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment of notes payable (37,875) (87,583)
Proceeds from issuance of convertible debentures 350,400 825,000
Payment of issuance costs (40,000) (59,035)
Proceeds from advances on shareholder revolving note 186,500   
Repayment of advances on shareholder revolving note (45,820) (36,120)
Net cash provided by financing activities 413,205 642,262
Net increase (decrease) in cash (17,151) (6,681)
Cash at beginning of period 23,316 37,325
Cash at end of period 6,165 30,644
Cash paid during the period for:    
Interest 276,697 180,244
Non-cash investing and financing activities during the period:    
Conversion of Series A preferred stock to common stock 150,000   
Conversion of Series B preferred stock to common stock 25,000 270,000
Common stock warrants issued with debentures 511,765 471,642
Extinguishment of convertible debentures in refinancing 1,265,384 300,000
Extinguishment of stock warrants in refinancing 88,536 136,363
Conversion of note payable to convertible debenture    250,000
Beneficial conversion feature of convertible debentures    303,388
Common stock issued for acquisition of non-controlling interest    721,386
Cancellation of note payable in acquisition of non-controlling interest    $ 17,758